346: Zealand's obesity strategy and Immunovant's curious development plan
The Readout Loud
Intro
This chapter explores the dynamic changes in the biotechnology industry, spotlighting Zealand Pharma's new obesity treatment and its collaboration with Roche. Additionally, it presents key updates from ImmuneVent and important discussions from a recent summit in New York.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
